Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...
The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...
Scorpion Capital said in a newly-issued short report that in “20 years of shorting, TransMedics (TMDX) is the most extreme and grotesque ...
NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...
TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...
Despite a Q3 revenue miss and temporary issues, TransMedics' long-term growth prospects remain strong, with plans for ...
The first international commercial flight since the fall of former Syrian President Bashar Assad has landed Tuesday at the Damascus airport arriving from Qatar DAMASCUS, Syria -- The first ...
Justin Trudeau’s decision to step down and prorogue Parliament will keep his government from implementing its proposed changes to capital gains for now, but Canadians might not be off the hook ...
The mutual fund (MF) industry’s demand for restoration of the indexation benefit when capital gains are computed on the sale of debt-oriented funds may be considered favourably by the government.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback